BCYC
BICYCLE THERAPEUTICS PLC
Next earnings Aug 6, 2026 · consensus $-0.58 EPS, $4.52M rev
Last earnings -0.2% on 2026-04-30
$4.10
▲ +2.24%$4.10▼ -44.74%
over 1Y
L $3.96EODHDH $8.87
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.2%
1W+0.2%
1M-12.3%
3M-10.9%
YTD-40.0%
1Y-46.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 18 analysts
Buy
Revenue grew 105.8% YoY; but unprofitable (net margin -301.7%).
BICYCLE THERAPEUTICS PLC shows $72.6M in FY2025 revenue (+105.8% YoY), a -301.7% net margin, and -35.9% ROE.
Sources: SEC EDGAR (CIK 0001761612, latest 10-Q filed 2026-04-30) · EODHD · as of 6/26/2026, 6:40:55 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.